Pharmaceuticals, Biotechnology and Life Sciences
– PDUFA action date set for October 25, 2025 – – sNDA being reviewed under FDA’s RTOR program – – Revumenib…
CHICAGO, June 24, 2025 (GLOBE NEWSWIRE) — Abvance Therapeutics, a biotechnology company developing next-generation glucagon analogs and therapies to prevent…
Aggregated presentation by day and by market Statement of transactions in own shares…
REDMOND, Wash., June 24, 2025 (GLOBE NEWSWIRE) — Inventprise, a clinical stage vaccine invention company, today announced the publication of…
CHICAGO, June 24, 2025 (GLOBE NEWSWIRE) — Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated…
Revolutionary Canine Supplement Promotes Regenerative Healing Through Stem Cell ActivationLAS VEGAS , June 24, 2025 (GLOBE NEWSWIRE) — via IBN…
New platform brings erectile dysfunction, weight loss, and wellness support directly to individuals through virtual pharmacist care and nationwide deliveryORLANDO,…
– Near doubling of 1-year overall survival (OS), increased median OS of 4 months (12.5 vs 8.5 months), and 43%…
How Parkinson’s affects million – and why current treatments are not enoughContinuous dopaminergic stimulation (CDS): a next-gen approach to Parkinson’s…
TORONTO, June 23, 2025 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced…